Reply to comment on "The risk assessment of uveitis after COVID-19 diagnosis by Wu et al. 2024"

被引：0
|
作者：
Hsu, Alan Y. [1 ]
Lin, Chun-Ju [1 ,2 ,3 ,12 ]
Hsia, Ning-Yi [1 ,2 ,3 ]
Wang, Yu-Hsun [4 ]
Li, Jing-Xing [4 ,5 ,6 ]
Chen, Huan-Sheng [7 ]
Wei, James Cheng-Chung [4 ,8 ,9 ,10 ,11 ,13 ]
Tsai, Yi-Yu [1 ,2 ,3 ]
机构：
[1] China Med Univ, China Med Univ Hosp, Dept Ophthalmol, Taichung, Taiwan
[2] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan
[3] Asia Univ, Dept Optometry, Taichung, Taiwan
[4] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan
[5] China Med Univ Hosp, Dept Gen Med, Taichung, Taiwan
[6] Natl Taiwan Univ, Inst Clin Lab Sci & Med Biotechnol, Taipei, Taiwan
[7] NephroCare Ltd, An Shin Dialysis Ctr, Fresenius Med Care, Taichung, Taiwan
[8] Chung Shan Med Univ, Inst Med, Taichung, Taiwan
[9] Chung Shan Med Univ Hosp, Dept Allergy Immunol & Rheumatol, Taichung, Taiwan
[10] China Med Univ, Inst Integrated Med, Taichung, Taiwan
[11] Chung Shan Med Univ, Dept Nursing, Taichung, Taiwan
[12] 2 Yude Rd, Taichung 404327, Taiwan
[13] 110,Sect 1,Jianguo N Rd, Taichung 402306, Taiwan
来源：
JOURNAL OF MEDICAL VIROLOGY | 2024年 / 96卷 / 05期
关键词：
D O I：
10.1002/jmv.29636
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Comment on "The risk assessment of uveitis after COVID-19 diagnosis"
    Wu, Patrick
    Yii, Chin-Yuan
    Yong, Su-Boon
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (03)
  • [2] Reply to Wu et al.: Commentary on insomnia and risk of mortality
    Wang, Jiancheng
    Pan, Bei
    Ge, Long
    SLEEP MEDICINE REVIEWS, 2020, 50
  • [3] Wildlife markets, COVID-19 and totalitarianism: A comment on Cawthorn et al.
    Ronald I. Orenstein
    Ambio, 2021, 50 : 1760 - 1761
  • [4] Wildlife markets, COVID-19 and totalitarianism: A comment on Cawthorn et al.
    Orenstein, Ronald I.
    AMBIO, 2021, 50 (09) : 1760 - 1761
  • [5] Reply to Volkman et al. Comment on "Fust et al. The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan. Vaccines 2024, 12, 434"
    Kohli, Michele
    Joshi, Keya
    Beck, Ekkehard
    Hagiwara, Yuriko
    Van de Velde, Nicolas
    Igarashi, Ataru
    VACCINES, 2024, 12 (10)
  • [6] The risk assessment of uveitis after COVID-19 diagnosis: A multicenter population-based study
    Hsia, Ning-Yi
    Hsu, Alan Y.
    Wang, Yu-Hsun
    Li, Jing-Xing
    Chen, Huan-Sheng
    Wei, James Cheng-Chung
    Lin, Chun-Ju
    Tsai, Yi-Yu
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (10)
  • [7] Risk of Uveitis Following COVID-19 Diagnosis
    Shao, Ping
    Chen, Irene J.
    Hymowitz, Maggie
    Breskin, Alexander
    Keebler, Daniel
    Sobel, Rachel E. E.
    Manthripragada, Angelika
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 75 - 76
  • [8] Comment on 'COVID-19: a major cause of cachexia and sarcopenia' by Morley et al.
    Zhou, Ling
    Liu, Cunming
    Yang, Chun
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2021, 12 (01) : 233 - 234
  • [9] Comment on "Neuromuscular complications after COVID-19 vaccination: a series of eight patients" by Leemans et al.
    Galassi, Giuliana
    Ariatti, Alessandra
    ACTA NEUROLOGICA BELGICA, 2023, 123 (04) : 1605 - 1606
  • [10] Comment on “Neuromuscular complications after COVID-19 vaccination: a series of eight patients” by Leemans et al.
    Giuliana Galassi
    Alessandra Ariatti
    Acta Neurologica Belgica, 2023, 123 : 1605 - 1606
12345